 | RICHARD F JACOBSDepartments of Pediatrics, | University of Arkansas for Medical Sciences, Little Rock | University of Arkansas for Medical Sciences, Little Rock (R.F.J.) | Division of ... |
Is this your profile? Claim your profile Copy URL Embed Link to your profile |
RICHARD F JACOBS:Expert Impact
Concepts for whichRICHARD F JACOBShas direct influence:Infectious mononucleosis,Neonatal herpes,Laryngeal candidiasis,Oral acyclovir,Oral acyclovir suppression,Congenital malaria,Hsv disease,Tuberculin test tuberculosis.
RICHARD F JACOBS:KOL impact
Concepts related to the work of other authors for whichfor which RICHARD F JACOBS has influence:Congenital malaria,Simplex virus,Neonatal herpes,Viral infections,Hsv infection,Newborn infant,Blood transfusion.
KOL Resume for RICHARD F JACOBS
| Year | |
|---|---|
| 2018 | Departments of Pediatrics, |
| 2015 | University of Arkansas for Medical Sciences, Little Rock |
| 2011 | University of Arkansas for Medical Sciences, Little Rock (R.F.J.) |
| 2004 | Division of Infectious Diseases, Department of Pediatrics, Medical College of Georgia, Augusta, GA 30912 (Murray) Division of Infectious Diseases, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72202 (Jacobs) |
| 1988 | From the Department of Pediatrics, University of California, San Francisco and San Francisco General Hospital, San Francisco, CA (MG); Chest Service, University of California, San Francisco and San Francisco General Hospital, San Francisco, CA (PCH); Department of Pediatric Infectious Diseases, Arkansas Children's Hospital, Little Rock, AR (RFJ), Department of Pediatrics, Medical College of Virginia, Health Sciences Division, Virginia Commonwealth University and St. Mary's Hospital, Richmond, VA (ELK); and Department of Pediatrics–Section of Infectious Diseases, Tulane University School of Medicine, New Orleans, LA (MHDS). Associate Professor of Pediatrics, Infectious Diseases/Immunology Arkansas Children's Hospital Little Rock, AR 72202 |
| 1986 | From the Departments of Pediatrics (BJT, RFJ, RLB) and Microbiology/Immunology (EMB), University of Arkansas for Medical Sciences, and The American Red Cross Blood Services, Arkansas Region (BEM, GS), Little Rock, AR. |
| 1983 | From the Deparment of Pediatrics, University of Arkansas for Medical Sciences, and Arkansas State Health Department, Little Rock, AR. |
| 1982 | Department of Medicine, University of Washington School of Medicine, Seattle, Wash. USA |
| 1978 | Little Rock, Ark., USA |
| Concept | World rank |
|---|---|
| postvaricella | #14 |
| chlorpropamide diazoxide | #15 |
| osteomyelitis complication | #19 |
| frozen deglycerolized | #21 |
| deglycerolized blood | #23 |
| tularemia children | #33 |
| hsv disease neonates | #35 |
| neonates hsv disease | #36 |
| oral acyclovir suppression | #39 |
| laryngeal candidiasis | #41 |
| enterovirus sepsis | #41 |
| complication varicella | #41 |
| tularensis gentamicins | #53 |
| neonates enterovirus | #56 |
| cmv viruria | #60 |
| acyclovir infants | #65 |
| preschool cilastatin | #69 |
| parenteral acyclovir | #81 |
Prominent publications by RICHARD F JACOBS
BACKGROUND: Poor neurodevelopmental outcomes and recurrences of cutaneous lesions remain unacceptably frequent among survivors of neonatal herpes simplex virus (HSV) disease.
METHODS: We enrolled neonates with HSV disease in two parallel, identical, double-blind, placebo-controlled studies. Neonates with central nervous system (CNS) involvement were enrolled in one study, and neonates with skin, eye, and mouth involvement only were enrolled in the other. After completing a regimen of 14 ...
| Known for Neonatal Herpes | Oral Acyclovir | Hsv Disease | 6 Months | Cns Involvement |
A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis
[ PUBLICATION ]
BACKGROUND: Neonatal enterovirus sepsis has high mortality. Antiviral therapy is not available.
METHODS: Neonates with suspected enterovirus sepsis (hepatitis, coagulopathy, and/or myocarditis) with onset at ≤15 days of life were randomized 2:1 to receive oral pleconaril or placebo for 7 days. Serial virologic (oropharynx, rectum, urine, serum), clinical, pharmacokinetic, and safety evaluations were performed.
RESULTS: Sixty-one subjects were enrolled (43 treatment, 18 placebo), of whom ...
| Known for Enterovirus Sepsis | Antiviral Therapy | Infections Female | Newborn Male | Oxadiazoles Oxazoles |
| Known for Congenital Malaria | Report Cases | Chloroquine Female | Maternal Fetal | Asia Southeastern |
Intravenous infusion of diazoxide in the treatment of chlorpropamide-induced hypoglycemia
[ PUBLICATION ]
| Known for Chlorpropamide Diazoxide | Intravenous Infusion | Humans Hypoglycemia |
An effective faculty mentoring program (FMP) is 1 approach that academic departments can use to promote professional fulfillment, faculty retention, and mitigate the risks of faculty burnout. Mentoring has both direct benefits for junior faculty mentees as they navigate the academic promotion process with their mentors, in addition to broader departmental and institutional benefits, with regard to recruitment, retention, and academic productivity. We describe a successful FMP model that ...
| Known for Humans Satisfaction |
Age-Dependent Effects of Aminobutyryl Muramyl Dipeptide on Alveolar Macrophage Function in Infant and Adult Macaca Monkeys1–5
[ PUBLICATION ]
We compared the antimicrobial function of alveolar macrophages (AM) from adult and 3- to 5-wk-old infant primates (Macaca nemestrina) and the effects of the immunomodulator, aminobutyryl muramyl dipeptide (abu-MDP) on this function. Phagocytosis of Staphylococcus aureus (SA) and group B streptococcus (GBS) by adult and infant AM was comparable. Adult and infant AM killed SA equally within 15 min of incubation; however, after 45 min, with phagocytosis of additional bacteria, adult AM had ...
